New Millennium Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.86K Buy
+100
New +$4.86K ﹤0.01% 256
2023
Q2
Sell
-16
Closed -$724 420
2023
Q1
$724 Hold
16
﹤0.01% 379
2022
Q4
$650 Hold
16
﹤0.01% 416
2022
Q3
$1K Hold
16
﹤0.01% 326
2022
Q2
$1K Buy
+16
New +$1K ﹤0.01% 327